OPKO Health/$OPK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OPKO Health
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Ticker
$OPK
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
2,997
ISIN
US68375N1037
Website
OPKO Health Metrics
BasicAdvanced
$1B
-
-$0.06
1.42
-
Price and volume
Market cap
$1B
Beta
1.42
52-week high
$2.04
52-week low
$1.19
Average daily volume
3.4M
Financial strength
Current ratio
2.493
Quick ratio
1.473
Long term debt to equity
28.056
Total debt to equity
34.025
Interest coverage (TTM)
-5.67%
Profitability
EBITDA (TTM)
-172.358
Gross margin (TTM)
15.22%
Net profit margin (TTM)
-5.66%
Operating margin (TTM)
-39.06%
Effective tax rate (TTM)
-6,628.28%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
-8.20%
Return on equity (TTM)
-3.04%
Valuation
Price to revenue (TTM)
1.282
Price to book
0.66
Price to tangible book (TTM)
12.12
Price to free cash flow (TTM)
-4.286
Free cash flow yield (TTM)
-23.33%
Free cash flow per share (TTM)
-30.10%
Growth
Revenue change (TTM)
-13.78%
Earnings per share change (TTM)
-83.30%
3-year revenue growth (CAGR)
-23.81%
10-year revenue growth (CAGR)
21.43%
3-year earnings per share growth (CAGR)
-31.70%
10-year earnings per share growth (CAGR)
-20.54%
What the Analysts think about OPKO Health
Analyst ratings (Buy, Hold, Sell) for OPKO Health stock.
Bulls say / Bears say
OPKO Health reported a net income of $14.0 million in Q4 2024, a significant turnaround from the $66.5 million net loss in the same quarter of the previous year, indicating improved financial performance. (stocktitan.net)
The company secured $51 million in additional funding from BARDA for COVID and influenza programs, enhancing its research and development capabilities. (stocktitan.net)
OPKO Health announced a $100 million increase to its existing share repurchase program, demonstrating confidence in its financial position and commitment to returning value to shareholders. (reuters.com)
Despite the net income in Q4 2024, OPKO Health reported an operating loss of $33.1 million in the same quarter, indicating ongoing operational challenges. (stocktitan.net)
Product revenue declined to $37.4 million in Q4 2024 from $43.0 million in the previous year, reflecting potential issues in product sales performance. (stocktitan.net)
Diagnostic services revenue decreased to $103.1 million in Q4 2024 from $124.2 million year-over-year, suggesting a downturn in this segment. (stocktitan.net)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
OPKO Health Financial Performance
Revenues and expenses
OPKO Health Earnings Performance
Company profitability
OPKO Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OPKO Health stock?
OPKO Health (OPK) has a market cap of $1B as of June 26, 2025.
What is the P/E ratio for OPKO Health stock?
The price to earnings (P/E) ratio for OPKO Health (OPK) stock is 0 as of June 26, 2025.
Does OPKO Health stock pay dividends?
No, OPKO Health (OPK) stock does not pay dividends to its shareholders as of June 26, 2025.
When is the next OPKO Health dividend payment date?
OPKO Health (OPK) stock does not pay dividends to its shareholders.
What is the beta indicator for OPKO Health?
OPKO Health (OPK) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.